SCHEMBL4986045

SCHEMBL4986045

NC(=O)c1n[c]c2c(n1)CN(C(=O)Cc1ccc(F)cc1)CC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 1/20 0.41
USP2 O75604 1/20 0.40
KCNK3 O14649 1/20 0.39
ME2 P23368 1/20 0.39
ME1 P48163 1/20 0.39
ME3 Q16798 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPT P10636 1/20 0.38
HSD11B1 P28845 1/20 0.38
KDR P35968 1/20 0.38
DPP4 P27487 2/20 0.37
DPP8 Q6V1X1 2/20 0.37
DPP7 Q9UHL4 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
MCHR1 Q99705 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4989356 0.89 NPC1 (0.42) POLBALDH1A1USP2KCNK3ME2
SCHEMBL4990959 0.87 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1KMT2AMAPTRAB9A
SCHEMBL4982974 0.84 GRM5 (0.45)
SCHEMBL4983744 0.83 HTT (0.49) SMN1; SMN2ALDH1A1MEN1KMT2ANPC1
SCHEMBL4988549 0.83 GRM2 (0.43) SMN1; SMN2ALDH1A1MEN1KMT2ARAB9A
SCHEMBL4983019 0.79 SIGMAR1 (0.47) POLBALDH1A1MEN1KMT2AMAPT
SCHEMBL4988103 0.79 GPR183 (0.37) MEN1KMT2ALMNATSHRMAPK1
SCHEMBL4985089 0.78 KDM4E (0.42) SMN1; SMN2MEN1KMT2ADPP4MAPK1
SCHEMBL4986741 0.78 PARP1 (0.41)
SCHEMBL4980948 0.77 MEN1 (0.49) POLBSMN1; SMN2ALDH1A1USP2ME2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof RENOVIS, INC. 2008-02-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 POLB 3676/4885SMN1; SMN2 4369/4885ALDH1A1 3640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.